Thymoma classification

Revision as of 17:54, 28 September 2015 by Ahmad Al Maradni (talk | contribs)
Jump to navigation Jump to search

Thymoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thymoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Thymoma classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Thymoma classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thymoma classification

CDC on Thymoma classification

Thymoma classification in the news

Blogs on Thymoma classification

Directions to Hospitals Treating Thymoma

Risk calculators and risk factors for Thymoma classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]

Overview

In 1999, a World Health Organization Working group suggested a non-committal terminology (Masaoka classification) for thymoma, preserving the distinct categories of the histogenetic classification, by using letters and numbers to designate tumor entities. Recently, it has been very well accepted as it provides an easy comparison of clinical, pathological and immunological studies.[1]

Pathologic Classification

The World Health Organization histologic classification of thymic epithelial tumors can be divided according to the degree of differentiation into[2]

Type Description
A A tumor composed of a population of neoplastic thymic epithelial cells having spindle/oval shape, lacking nuclear atypia, and accompanied by few or no nonneoplastic lymphocytes
AB A tumor in which foci having the features of type A thymoma are admixed with foci rich in lymphocytes
B1 A tumor that resembles the normal functional thymus in that it combines large expanses having an appearance practically indistinguishable from normal thymic cortex with areas resembling thymic medulla
B2 A tumor in which the neoplastic epithelial component appears as scattered plump cells with vesicular nuclei and distinct nucleoli among a heavy population of lymphocytes. Perivascular spaces are common and sometimes very prominent. A perivascular arrangement of tumor cells resulting in a palisading effect may be seen.
B3 A type of thymoma predominantly composed of epithelial cells having a round or polygonal shape and exhibiting no or mild atypia. They are admixed with a mild component of lymphocytes, resulting in a sheet-like growth of the neoplastic epithelial cells.
C A thymic tumor (thymic carcinoma) exhibiting clear-cut cytologic atypia and a set of cytoarchitectural features no longer specific to the thymus, but rather analogous to those seen in carcinomas of other organs. Type C thymomas lack immature lymphocytes; whatever lymphocytes may be present are mature and usually admixed with plasma cells.

References

  1. "http://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb10/BB10.pdf" (PDF). External link in |title= (help)
  2. "WHO histologic classification is a prognosti... [Ann Thorac Surg. 2004] - PubMed - NCBI".